sodium
2005
111in
versu
molecular
nurmaya
change
100
125I
reaction
benzyl
meoh
68ga
ogawa
solvent
100oc
37oc
akira
yoji
modification
other
mobile
shiba3
using
formic
2014
tri
kitamura3
blood
temperature
selective
diagnostic
introduction
benzimidazole
intravenously
tissue
studie
patent
each
toluene
flow
agent
needed
PDGFR
added
tyrosine
365
developing
injection
phosphoryl
trifluoromethanesulfonimide
TKR
counter
hydrogen
rate
receptor
2000
stability
123I
research
CP
partition
fold
conjugation
important
centrifuged
muscle
ATE
binaphthyl
mishiro
75oc
BALB
male
2institute
respectively
nai
overexpressed
3advanced
coefficient
II
diphenylphosphino
photon
value
platelet
UV
stable
low
radioisotope
dichloromethane
target
time
odani1
kazuhiro
acetic
during
451
bxpc3
NCS
used
vortexed
positron
micea
kenji2
U87MG
carbonate
673
PET
water
information
200
SD
science
inhibitor
complex
dose
method
tumor
chcl3
variety
radiolabeled
ratio
hepatobiliary
B1
235825
growth
hea
acetate
intact
wa
95oc
PDGFRα
summary
malignant
anticancer
iodid
expression
2013
drug
medium
measured
bromide
log
incubation
blocking
normal
excretion
stood
sacrificed
weight
octanol
yield
vivo
nuclear
PBS
kidn
post
re
conveniently
concept
radioligand
inhibitor1
week
EP
monitor
purity
control
40oc
biodistribution
5005
ethane
derived
2360
diisopropylethylamine
group
nbutylstannyl
kinase
small
liv
chloride
single
therapy
trifluoroacetic
mainly
chem
lee
lysed
ID
factor
IB
refluxed
radioactivity
IC50
chlorosuccinimide
methanol
derivative
one
2chem
room
oxidizing
asses
1pharmaceutical
IQP
PDGFRβ
radiotracer
emission
university
2006
SIB
mean
gram
SPECT
tungstate
higher
bi
150
modalitie
MCF7
than
med
molecule
potent
medicine
min
effendi1
dimethylformamide
methanesulfonyl
bearing
ligand
F7
formamidine
mice
additional
2016
001
radiochemical
injected
represent
computed
analysi
demonstrated
99mtc
initiative
60oc
structural
triethylamine
frontier
prepared
might
succinimidyl
variou
protein
provide
kanazawa
vitro
DCM
peroxide
new
expressed
11C
palladium
organic
european
esti
beta
cell
repeated
visualization
synthesized
tomography
incubated
phenyl
iododestannylation
imaging
three
november
center
18F
through
metabolite
level
result
respond
per
high
female
kazuma1
give
more
ddy
TLC
pathway
benzoate
uptake
cancer
accumulation
5C18MS
DIPEA
synthesi
dibenzylideneacetone
phase
cesium
four
acoh
acid
column
specification
between
dihydrate
957
evaluation
potassium
dipalladium